Medeon Biodesign, Inc. researches, develops, manufactures, and sells medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, a solution to view throughout laparoscopic surgeries; and AbClose to prevent port site herniation caused by improper closure. It is involved in the medical device contract manufacturing; and manufacture and sale of injection molding and components of medical devices. The company was incorporated in 2012 and is based in Taipei, Taiwan.
Metrics to compare | 6499 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship6499PeersSector | |
---|---|---|---|---|
P/E Ratio | −12.6x | −206.8x | −0.5x | |
PEG Ratio | −0.35 | −2.31 | 0.00 | |
Price/Book | 7.3x | 6.3x | 2.6x | |
Price / LTM Sales | 28.4x | 10.0x | 3.3x | |
Upside (Analyst Target) | 35.5% | 0.0% | 43.5% | |
Fair Value Upside | Unlock | −14.7% | 6.9% | Unlock |